Don't sell your shares. Wait for the news if you must. Make them pay a premium., page-69

OCC has a history of spiking before positive announcements. Crazy to sell before it hits!

Any positive news re CelGro for nerve repair will imo be a powerful catalyst. With the previous interim readout in Oct 2019 reporting 96% of nerve repairs restored voluntary movement to previously paralysed muscles any additional readouts will attract media attention.

A marketing strategy further utilizing patients like Adrian Walsh (a quadriplegic participant in the study) which focuses on improvements in movement and quality of life will be particularly impactful for the sp. Post surgery utilizing CelGro Adrian was able to complete a renovation, take up wheelchair rugby, and has enrolled to study project and construction management. A remarkable achievement worth sharing and promoting!

The potential in this company is significant and warrants a long term outlook imo.